# National Longitudinal Cohort of Hematological Diseases

> **NCT04645199** · — · RECRUITING · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 2300 (estimated)

## Conditions studied

- Multiple Myeloma
- Acute Myeloid Leukemia
- Hemophilia
- Hemophilia A
- Hemophilia B
- Myelodysplastic Syndrome
- MDS
- Lymphoma
- Leukemia
- Aplastic Anemia
- Bleeding Disorder
- Bone Marrow Transplantation
- Blood Disease Infection
- Autoimmune Hemolytic Anemia, AIHA
- Essential Thrombocythemia, ET
- Large Granular Lymphocyte Leukemia, LGLL
- Paroxysmal Nocturnal Hemoglobinuria, PNH

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04645199
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-12-01
- **Primary completion:** 2030-12-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 2300 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04645199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04645199, "National Longitudinal Cohort of Hematological Diseases". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04645199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*